KCT0004249尚未招募未知
Efficacy and Safety of Terazosin 4mg in patients with Benign Prostataic Hyperplasia assciated with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: single center, single-arm, prospective study
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- Male
入选标准
- •? Men over 19
- •? Those who have had pelvic pain for at least 3 months within the last 6 months
- •? Those who have an The National Institutes of Health Chronic Prostatitis Symptom Index(NIH-CPSI) score of 15 or higher
- •? Those who have 8 or more International Prostate Symptom Score(IPSS) score
- •? A person who voluntarily decides to participate in this study and agrees in writing to the subject's consent
排除标准
- •? Persons with hypersensitivity to hytrine-based drugs (a-blocker)
- •? Those who are taking cholinergic drugs and diuretics
- •? Those with urination disorders due to obvious causes other than enlarged prostate
- •? Those with urinary tract infection (midstream urine culture> 100,000 colonies / mL)
- •? Patients with clinically significant circulatory diseases (myocardial infarction, heart failure, angina pectoris, deep vein, pacemaker use, orthostatic hypotension, uncontrolled hypotension)
- •? Participants in other interventional clinical trials within 3 months of screening
- •? Those who have a past or present history of malignant tumors and are inappropriate for participation in research when judged by the research director or the person in charge of the research
- •? Patients with genetic problems such as galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption
- •? Other persons who are inappropriate to participate in research as judged by the research director or research manager
研究者
相似试验
尚未招募
不适用
Evaluation of efficacy and safety of terazosin in patients with benign prostatic hyperplasia with lower urinary tract symptomsKCT0005278Yonsei University, Wonju Severance Christian Hospital174
尚未招募
不适用
Evaluation of the Effectiveness of Terazosin in Patients with Nocturia due to Prostate HyperplasiaDiseases of The genitoruinary systemKCT0004837Hanyang University Guri Hospital82
尚未招募
不适用
A cross-over study of the effects of terazosin or tamsulosin on the efficacy and sexual function of lower urinary tract symptoms in patients with benign prostatic hyperplasiaDiseases of The genitoruinary systemKCT0004914lsan Univeristy Hospital76
已完成
2 期
A Phase II clinical trial to study the effects of TRC4186, an investigational new drug in patients with stable heart failure associated with HbA1C â?¥ 6.0% or type 2 diabetes mellitus receiving oral anti-diabetic drug with or without insulin.CTRI/2009/091/000043Torrent Pharmaceutical Ltd300
进行中（未招募）
1 期
Safety and efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1c >= 6 % or type 2 diabetes receiving oral hypoglycaemic therapy (with or without additional insulin) as an add-on to conventional treatment for heart failureheart failure associated with impaired glucose tolerance or type 2 diabetesMedDRA version: 9.1Level: LLTClassification code 10019279Term: Heart failureEUCTR2008-006237-27-NLTorrent Pharmaceuticals Ltd.300